Nuria Vilaplana-Lopera

6PUBLICATIONS
27CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Atmospheric aerosolsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2026
Tirapazamine sensitises hypoxic homologous recombination-proficient NSCLC to PARP inhibition.

|May 28, 2026
MAFF regulates ferroptotic sensitivity through iron homeostasis and fatty acid synthesis.

|Feb 05, 2026
Succinate receptor 1 restricts hematopoiesis and prevents acute myeloid leukemia progression.

Vincent Cuminetti, Emeline Boet, Marcel Heugel

|Sep 02, 2025
Tissue-specific iron levels modulate lipid peroxidation and the FLASH radiotherapy effect.

Nuria Vilaplana-Lopera, Jiyoung Kim, Gilyeong Nam

|Sep 02, 2022
Crosstalk between AML and stromal cells triggers acetate secretion through the metabolic rewiring of stromal cells.

Nuria Vilaplana-Lopera, Vincent Cuminetti, Ruba Almaghrabi

|Mar 29, 2021
MYBL2 and ATM suppress replication stress in pluripotent stem cells.

Daniel Blakemore, Nuria Vilaplana-Lopera, Ruba Almaghrabi

Pageof 1

Frequent Collaborators

3 joint publications

Eui Jung Moon

3 joint publications

Paloma García

2 joint publications

Vincent Cuminetti

2 joint publications

Lorena Arranz